| （単位：千ドル） | 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 研究開発費 | 21,553 | 39,948 | 55,317 | 46,224 | 25,108 | 14,788 | 3,101 | 5,868 | 9,674 | 6,882 | 23,966 | 30,078 | 15,814 | - |
| 営業費用 | 27,783 | 46,082 | 65,209 | 56,582 | 36,913 | 26,254 | 6,632 | 12,813 | 16,528 | 14,750 | 33,094 | 40,800 | 27,250 | - |
| 経常（税引前）利益 | -14,673 | -21,098 | - | - | - | - | -13,634 | -12,687 | -16,395 | - | - | - | - | - |
| 純利益 | -14,673 | -21,098 | -31,849 | -26,240 | -16,801 | -20,129 | -10,583 | -12,687 | -16,395 | -14,730 | -33,152 | -42,350 | -29,815 | -39,827 |
| 一株あたり利益 | - | - | - | - | - | - | - | - | - | - | - | -4 | -1.5 | - |
| 希薄化後一株あたり利益 | - | - | - | - | - | - | - | - | - | - | - | -4 | -1.5 | - |